EUVIMEDEUVIMED entdecken
Crossref

Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study

Yidan Zhang, Yuan Zhao, Jian Zhang, Ya Gao, Xuan Gao, Shuyue Li, Cui Chang, Guofeng Yang

Journal of Proteomics · 2024

DOI: 10.1016/j.jprot.2024.105279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2024. Verfasst von Yidan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Proteomics, Extracellular Vesicles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) act as mediators for intercellular transfer of Aβ and tau proteins, promoting the propagation of these pathological misfolded proteins throughout the brain in Alzheimer's disease (AD). Levels of blood exosomal Aβ42, total Tau (t-Tau) and phosphorylated Tau (p-Tau) had a high correlation with their concentrations in cerebrospinal fluid (CSF), demonstrating that exosomal biomarkers have equal contribution as those in CSF for the diagnosis of AD. We aimed to comprehensively characterize the proteome of plasma-derived EVs to identify differentially expressed proteins (DEPs) and pathways in AD. Tandem mass tag (TMT) labeled quantitative proteomics was applied to analyze plasma-derived EV proteins in 9 AD patients and 9 healthy controls. 335 proteins were quantified, and 12 DEPs were identified including seven upregulated proteins and five down-regulated proteins. Oligomerized Aβ1-42 induced SH-SY5Y cell damage model was built to mimic the pathological changes of AD, and small interfering RNA (siRNA) against S100A8 was used to knock down S100A8 expression. Results displayed S100A8 was down regulated in plasma-derived EVs from AD patients, while enriched in EVs derived from Aβ1-42-induced SH-SY5Y cells. Furthermore, Aβ1-42-induced SH-SY5Y cells treated with S100A8 siRNA showed decreased Aβ levels in cell lysate and EVs, especially in EVs. SIGNIFICANCE: The investigation aimed to comprehensively characterize the proteome of plasma-derived EVs to identify DEPs and potential biomarker of AD. S100A8 was found down regulated in plasma-derived EVs from AD patients using TMT labeled quantitative proteomics. The diagnostic value of S100A8 was also confirmed using receiver operating characteristic curve (ROC) analysis. Furthermore, Aβ1-42-induced SH-SY5Y cells treated with S100A8 siRNA showed decreased Aβ levels in cell lysate and EVs, especially in EVs. The preliminary findings suggest that suppression of S100A8 expression inhibits Aβ aggregation both in cell lysate and EVs from Aβ1-42-induced SH-SY5Y cells, and S100A8 more likely regulates Aβ aggregation via EVs. Therefore, plasma-derived EV S100A8 might be a potential biomarker of AD. Manipulation of S100A8 expression may be a novel therapeutic strategy in the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersProteomicsExtracellular VesiclesCalgranulin AHumansMaleFemaleAgedCell Line, TumorAmyloid beta-PeptidesMiddle AgedProteome

Stichwörter der Autor:innen

Alzheimer's diseaseBiomarkerExtracellular vesiclesProteomicsS100A8siRNA

Substanzen

BiomarkersS100A8 protein, humanCalgranulin AAmyloid beta-PeptidesProteome

Autor:innen und Institutionen

  • Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Electronic address: gf_yang71@126.com.

Zitieren

APA

Zhang, Y., Zhao, Y., Zhang, J., Gao, Y., Gao, X., Li, S., Chang, C., & Yang, G. (2024). Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2024.105279

Vancouver

Zhang Y, Zhao Y, Zhang J, Gao Y, Gao X, Li S, et al. Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study. Journal of Proteomics. 2024. doi:10.1016/j.jprot.2024.105279

BibTeX
@article{Zhang2024,
  author = {Zhang, Yidan and Zhao, Yuan and Zhang, Jian and Gao, Ya and Gao, Xuan and Li, Shuyue and Chang, Cui and Yang, Guofeng},
  title = {Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study},
  journal = {Journal of Proteomics},
  year = {2024},
  doi = {10.1016/j.jprot.2024.105279}
}
Kostenlos starten →